140 related articles for article (PubMed ID: 16504183)
1. Regulation of the transcription factor FOXM1c by Cyclin E/CDK2.
Lüscher-Firzlaff JM; Lilischkis R; Lüscher B
FEBS Lett; 2006 Mar; 580(7):1716-22. PubMed ID: 16504183
[TBL] [Abstract][Full Text] [Related]
2. FOXM1c is activated by cyclin E/Cdk2, cyclin A/Cdk2, and cyclin A/Cdk1, but repressed by GSK-3alpha.
Wierstra I; Alves J
Biochem Biophys Res Commun; 2006 Sep; 348(1):99-108. PubMed ID: 16875671
[TBL] [Abstract][Full Text] [Related]
3. Cyclin E/Cdk2, P/CAF, and E1A regulate the transactivation of the c-myc promoter by FOXM1.
Wierstra I; Alves J
Biochem Biophys Res Commun; 2008 Mar; 368(1):107-15. PubMed ID: 18206647
[TBL] [Abstract][Full Text] [Related]
4. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2.
Du WW; Yang W; Liu E; Yang Z; Dhaliwal P; Yang BB
Nucleic Acids Res; 2016 Apr; 44(6):2846-58. PubMed ID: 26861625
[TBL] [Abstract][Full Text] [Related]
5. Cyclin D1/Cdk4 increases the transcriptional activity of FOXM1c without phosphorylating FOXM1c.
Wierstra I
Biochem Biophys Res Commun; 2013 Feb; 431(4):753-9. PubMed ID: 23333330
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor FOXM1c is repressed by RB and activated by cyclin D1/Cdk4.
Wierstra I; Alves J
Biol Chem; 2006 Jul; 387(7):949-62. PubMed ID: 16913845
[TBL] [Abstract][Full Text] [Related]
7. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
Morris L; Allen KE; La Thangue NB
Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
[TBL] [Abstract][Full Text] [Related]
8. The central domain of transcription factor FOXM1c directly interacts with itself in vivo and switches from an essential to an inhibitory domain depending on the FOXM1c binding site.
Wierstra I; Alves J
Biol Chem; 2007 Aug; 388(8):805-18. PubMed ID: 17655499
[TBL] [Abstract][Full Text] [Related]
9. Inducible pRb2/p130 expression and growth-suppressive mechanisms: evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback regulatory loop.
Howard CM; Claudio PP; De Luca A; Stiegler P; Jori FP; Safdar NM; Caputi M; Khalili K; Giordano A
Cancer Res; 2000 May; 60(10):2737-44. PubMed ID: 10825149
[TBL] [Abstract][Full Text] [Related]
10. The cell-cycle regulated transcription factor B-Myb is phosphorylated by cyclin A/Cdk2 at sites that enhance its transactivation properties.
Saville MK; Watson RJ
Oncogene; 1998 Nov; 17(21):2679-89. PubMed ID: 9840932
[TBL] [Abstract][Full Text] [Related]
11. An N-terminal inhibitory domain modulates activity of FoxM1 during cell cycle.
Park HJ; Wang Z; Costa RH; Tyner A; Lau LF; Raychaudhuri P
Oncogene; 2008 Mar; 27(12):1696-704. PubMed ID: 17891172
[TBL] [Abstract][Full Text] [Related]
12. Protein phosphatase 2A (B55α) prevents premature activation of forkhead transcription factor FoxM1 by antagonizing cyclin A/cyclin-dependent kinase-mediated phosphorylation.
Alvarez-Fernández M; Halim VA; Aprelia M; Laoukili J; Mohammed S; Medema RH
J Biol Chem; 2011 Sep; 286(38):33029-36. PubMed ID: 21813648
[TBL] [Abstract][Full Text] [Related]
13. Raf/MEK/MAPK signaling stimulates the nuclear translocation and transactivating activity of FOXM1c.
Ma RY; Tong TH; Cheung AM; Tsang AC; Leung WY; Yao KM
J Cell Sci; 2005 Feb; 118(Pt 4):795-806. PubMed ID: 15671063
[TBL] [Abstract][Full Text] [Related]
14. Cyclin E-cdk2 activation is associated with cell cycle arrest and inhibition of DNA replication induced by the thymidylate synthase inhibitor Tomudex.
Yin MB; Guo B; Panadero A; Frank C; Wrzosek C; Slocum HK; Rustum YM
Exp Cell Res; 1999 Feb; 247(1):189-99. PubMed ID: 10047461
[TBL] [Abstract][Full Text] [Related]
15. Modulation of Sp1 activity by a cyclin A/CDK complex.
Haidweger E; Novy M; Rotheneder H
J Mol Biol; 2001 Feb; 306(2):201-12. PubMed ID: 11237594
[TBL] [Abstract][Full Text] [Related]
16. HIRA, the human homologue of yeast Hir1p and Hir2p, is a novel cyclin-cdk2 substrate whose expression blocks S-phase progression.
Hall C; Nelson DM; Ye X; Baker K; DeCaprio JA; Seeholzer S; Lipinski M; Adams PD
Mol Cell Biol; 2001 Mar; 21(5):1854-65. PubMed ID: 11238922
[TBL] [Abstract][Full Text] [Related]
17. FOXM1c transactivates the human c-myc promoter directly via the two TATA boxes P1 and P2.
Wierstra I; Alves J
FEBS J; 2006 Oct; 273(20):4645-67. PubMed ID: 16965535
[TBL] [Abstract][Full Text] [Related]
18. Site-directed mutant p21 proteins defective in both inhibition of E2F-regulated transcription and disruption of E2F-p130-cyclin-cdk2 complexes.
Robles SJ; Shiyanov P; Aristodemo GT; Raychaudhuri P; Adami GR
DNA Cell Biol; 1998 Jan; 17(1):9-18. PubMed ID: 9468218
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
20. The transcription factor FOXM1 (Forkhead box M1): proliferation-specific expression, transcription factor function, target genes, mouse models, and normal biological roles.
Wierstra I
Adv Cancer Res; 2013; 118():97-398. PubMed ID: 23768511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
